• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国的政策:后新冠疫情时代对老年人口的挑战。

China's policies: post-COVID-19 challenges for the older population.

机构信息

Law School, Shandong University, Weihai, China.

出版信息

Glob Health Action. 2024 Dec 31;17(1):2345968. doi: 10.1080/16549716.2024.2345968. Epub 2024 May 8.

DOI:10.1080/16549716.2024.2345968
PMID:38717833
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11080668/
Abstract

On 7 December 2022, the State Council of China released 'Measures to Further Optimize the Implementation of the Prevention and Control of the New Coronavirus Epidemic'. The previous three-year dynamic zero epidemic prevention policy was then replaced with a full liberalization policy. On 5 May 2023, the World Health Organization declared that COVID-19 no longer constituted a 'public health emergency of international concern.' However, given the ongoing prevalence of coronavirus, emerging mutations, and the liberalization of restrictions, there are increased risks of vulnerable people contracting new variants. Low vaccination coverage among older people with compromised immune systems, puts them at further risk. The policy shift will increase pressure on already stretched health infrastructure and medical resources. This short article adds to the current debate arguing that the Chinese government should take commensurate preventive measures, including strengthening medical facilities and equipment and targeting ongoing vaccination in older people.

摘要

2022 年 12 月 7 日,中国国务院发布《进一步优化落实新冠肺炎疫情防控措施的通知》。此前三年的动态清零防疫政策随后被全面放开政策所取代。2023 年 5 月 5 日,世界卫生组织宣布 COVID-19 不再构成“国际关注的突发公共卫生事件”。然而,考虑到冠状病毒的持续流行、新的突变以及限制的放宽,弱势群体感染新变种的风险增加。免疫系统受损的老年人疫苗接种率低,使他们面临更大的风险。政策的转变将给本已紧张的卫生基础设施和医疗资源带来更大的压力。这篇短文增加了当前的争论,即中国政府应该采取相应的预防措施,包括加强医疗设施和设备,并针对老年人进行持续的疫苗接种。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aafb/11080668/c79199232ce7/ZGHA_A_2345968_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aafb/11080668/19c28cf3096a/ZGHA_A_2345968_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aafb/11080668/c79199232ce7/ZGHA_A_2345968_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aafb/11080668/19c28cf3096a/ZGHA_A_2345968_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aafb/11080668/c79199232ce7/ZGHA_A_2345968_F0002_OC.jpg

相似文献

1
China's policies: post-COVID-19 challenges for the older population.中国的政策:后新冠疫情时代对老年人口的挑战。
Glob Health Action. 2024 Dec 31;17(1):2345968. doi: 10.1080/16549716.2024.2345968. Epub 2024 May 8.
2
Public Health Crises In Comparison: China's Epidemic Response Policies From SARS To COVID-19.公共卫生危机比较:中国从 SARS 到 COVID-19 的疫情应对政策。
Glob Public Health. 2021 Aug-Sep;16(8-9):1223-1236. doi: 10.1080/17441692.2021.1919735. Epub 2021 Apr 23.
3
Was China's zero-COVID policy the right choice? The multiple factor analysis of variables that affected the course of COVID-19 pandemic in China.中国的“动态清零”政策是正确的选择吗?影响中国 COVID-19 大流行进程的多因素变量分析。
Front Public Health. 2023 Dec 6;11:1252370. doi: 10.3389/fpubh.2023.1252370. eCollection 2023.
4
China's zero-COVID strategy: what happens next?中国的动态清零政策:接下来会怎样?
Nature. 2022 Feb;602(7895):15-16. doi: 10.1038/d41586-022-00191-7.
5
Impact of epidemic prevention policies on public vaccination willingness: empirical research in China.疫情防控政策对公众接种意愿的影响:中国的实证研究。
Front Public Health. 2024 Jul 3;12:1329228. doi: 10.3389/fpubh.2024.1329228. eCollection 2024.
6
[Technical guidelines for seasonal influenza vaccination in China (2021-2022)].《中国季节性流感疫苗接种技术指南(2021—2022年)》
Zhonghua Liu Xing Bing Xue Za Zhi. 2021 Oct 10;42(10):1722-1749. doi: 10.3760/cma.j.cn112338-20210913-00732.
7
Study on the Experience of Public Health System Construction in China's COVID-19 Prevention.中国新冠疫情防控公共卫生体系建设经验研究
Front Public Health. 2021 Apr 23;9:610824. doi: 10.3389/fpubh.2021.610824. eCollection 2021.
8
Achilles' heel: elderly COVID-19 vaccination policy in China.阿喀琉斯之踵:中国老年人的 COVID-19 疫苗接种政策。
Health Res Policy Syst. 2024 Aug 5;22(1):90. doi: 10.1186/s12961-024-01155-1.
9
China's model to combat the COVID-19 epidemic: a public health emergency governance approach.中国抗击新冠肺炎疫情的模式:公共卫生应急治理之道。
Glob Health Res Policy. 2020 Jul 14;5:34. doi: 10.1186/s41256-020-00161-4. eCollection 2020.
10
Development, Status Quo, and Challenges to China's Health Informatization During COVID-19: Evaluation and Recommendations.新冠疫情下中国卫生信息化的发展、现状与挑战:评估与建议。
J Med Internet Res. 2021 Jun 17;23(6):e27345. doi: 10.2196/27345.

引用本文的文献

1
Longitudinal study on the impact of public health event control measures on physical fitness among Chinese adolescents: a southern city perspective.公共卫生事件防控措施对中国青少年身体素质影响的纵向研究:以南方某城市为例
BMC Public Health. 2024 Dec 30;24(1):3615. doi: 10.1186/s12889-024-20751-y.
2
Factors influencing the time to COVID-19 antigen tests negative conversion among students at a Chinese university: a retrospective analysis.影响中国某大学学生新冠病毒抗原检测转阴时间的因素:一项回顾性分析
BMC Infect Dis. 2024 Dec 18;24(1):1443. doi: 10.1186/s12879-024-10346-8.
3
Development and validation of nomogram models for severe and fatal COVID-19.

本文引用的文献

1
Parametric analysis of the transmission dynamics during indigenous aggregated outbreaks caused by five SARS-CoV-2 strains in Nanjing, China.中国南京 5 种 SARS-CoV-2 株引起本土聚集性疫情传播动力学的参数分析。
Front Public Health. 2024 Mar 8;12:1358577. doi: 10.3389/fpubh.2024.1358577. eCollection 2024.
2
Estimate of COVID-19 Deaths, China, December 2022-February 2023.2022 年 12 月至 2023 年 2 月期间中国 COVID-19 死亡人数的估计。
Emerg Infect Dis. 2023 Oct;29(10):2121-2124. doi: 10.3201/eid2910.230585. Epub 2023 Aug 28.
3
Effectiveness of Chinese medicine formula Huashibaidu granule on mild COVID-19 patients: A prospective, non-randomized, controlled trial.
开发和验证严重和致命 COVID-19 的列线图模型。
Sci Rep. 2024 Nov 25;14(1):29146. doi: 10.1038/s41598-024-80310-8.
中药方剂化湿败毒颗粒对轻度新型冠状病毒肺炎患者的疗效:一项前瞻性、非随机对照试验
Integr Med Res. 2023 Jun;12(2):100950. doi: 10.1016/j.imr.2023.100950. Epub 2023 Apr 21.
4
Study on the COVID-19 epidemic in mainland China between November 2022 and January 2023, with prediction of its tendency.2022年11月至2023年1月中国大陆地区新冠疫情研究及其趋势预测
J Biosaf Biosecur. 2023 Mar;5(1):39-44. doi: 10.1016/j.jobb.2023.03.001. Epub 2023 Mar 22.
5
Global stability and analysing the sensitivity of parameters of a multiple-susceptible population model of SARS-CoV-2 emphasising vaccination drive.强调疫苗接种推动的新冠病毒多易感人群模型的全局稳定性及参数敏感性分析
Math Comput Simul. 2023 Jan;203:741-766. doi: 10.1016/j.matcom.2022.07.012. Epub 2022 Jul 23.
6
COVID or not COVID: attributing and reporting cause of death in a community cohort.新冠还是非新冠:社区队列中死亡原因的归因和报告。
Public Health. 2022 Apr;205:157-163. doi: 10.1016/j.puhe.2022.02.008. Epub 2022 Mar 11.
7
COVID-19 Vaccination Acceptance Among Chinese Population and Its Implications for the Pandemic: A National Cross-Sectional Study.《中国民众对 COVID-19 疫苗接种的接受程度及其对大流行的影响:一项全国性横断面研究》。
Front Public Health. 2022 Feb 8;10:796467. doi: 10.3389/fpubh.2022.796467. eCollection 2022.